Search results for: “UNM”
-
Loews Corporation Valuation – March 2019 #L
Loews Corporation is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years.
-
Anthem Inc Valuation – February 2019 $ANTM
Anthem Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PEmg and PB ratios.
-
Best Stocks Below Their Graham Number – February 2019
I’ve selected the best companies reviewed by ModernGraham which trade below their Graham Number. Â The companies selected all are found suitable for the Defensive Investor and/or the Enterprising Investor, and have been valued as undervalued based on the ModernGraham valuation model. Â
-
Arthur J Gallagher & Co Valuation – February 2019 $AJG
Arthur J Gallagher & Co is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the high PEmg and PB ratios.
-
Brighthouse Financial Inc Valuation – February 2019 $BHF
Brighthouse Financial Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg ratio.
-
Allstate Corp Valuation – February 2019 $ALL
Allstate Corp qualifies for both the Defensive Investor and the Enterprising Investor. In fact, the company meets all of the requirements of both investor types, a rare accomplishment indicative of the company’s strong financial position .
-
Hartford Financial Services Group Inc Valuation – February 2019 $HIG
Hartford Financial Services Group Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the high PEmg ratio.
-
Gilead Sciences Inc Valuation – January 2019 $GILD
Gilead Sciences, Inc. qualifies for both the Defensive Investor and the Enterprising Investor. The Defensive Investor is only initially concerned with the poor dividend history.
-
Nektar Therapeutics Valuation – November 2018 $NKTR
Nektar Therapeutics does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.
-
Supernus Pharmaceuticals Inc Valuation – August 2018 $SUPN
Supernus Pharmaceuticals Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.